Physician

David E Pallares, M.D.

According to 2025 Medicare claims, David Pallares, M.D. (NPI: 1023082484) practices allergy/immunology in the Louisville/Jefferson County, KY-IN market, with the plurality of this provider's patient population coming from Jefferson, KY. This provider's primary affiliated billing organization is PSF PLLC (NPI: 1881785947; TIN: 611389493) and primary practice location at 47129-8729. Pallares is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Pallares' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 401 traditional Medicare patients, billed 30,793 HCPCS/CPT codes, and received $515,459 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,985 prescription claims across 474 beneficiaries totaling $763,710 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). DME data shows 398 claims. Open Payments data shows 122 records totaling $3,074. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $87,663 to $515,459. Similarly, Part D prescription costs have moved sharply higher in recent years, from $118,727 to $763,710. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,157 to $9,133.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	207	9,312	$87,663
2016	201	9,641	$87,747
2017	210	9,592	$84,011
2018	311	8,308	$75,844
2019	529	8,934	$81,631
2020	480	13,525	$177,199
2021	498	14,091	$244,712
2022	419	12,450	$233,129
2023	305	19,878	$346,255
2024	401	30,793	$515,459

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	202	1,403	$118,727
2016	206	1,450	$147,159
2017	218	1,730	$178,731
2018	251	1,629	$224,372
2019	299	2,032	$304,963
2020	335	2,414	$345,294
2021	339	2,382	$345,179
2022	340	2,412	$778,146
2023	385	2,653	$803,567
2024	474	2,985	$763,710

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	178	$9,489
2016	N/R	136	$4,279
2017	N/R	127	$1,885
2018	N/R	81	$1,395
2019	39	213	$52,169
2020	45	324	$67,875
2021	17	286	$107,934
2022	N/R	169	$97,822
2023	25	259	$137,929
2024	39	398	$371,310

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	222	311	$84
94375	Test to measure rate of airflow	152	217	$26
95012	Test to measure the level of nitric oxide gas	136	186	$12
95165	Professional service for preparation and provision of 1 or more antigens	140	3,420	$10
95117	Professional service for multiple injections of allergen	168	2,897	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	32	896	$165,480
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	137	5,730	$119,453
Dupixent Pen	Dupilumab	14	392	$52,297
Breo Ellipta	Fluticasone/Vilanterol	75	3,450	$44,708
Spiriva Respimat	Tiotropium Bromide	56	2,100	$36,154

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1551	Injection, immune globulin (cutaquig), 100 mg	N	N/R	27	$146,511
J1556	Injection, immune globulin (bivigam), 500 mg	N	N/R	13	$82,946
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	26	$80,931
J1558	Injection, immune globulin (xembify), 100 mg	N	N/R	13	$46,225
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	17	$5,604

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	122	$3,074	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David E. Pallares, M.D.?

Tedicare shows public-source Medicare data for David E. Pallares, M.D. (NPI 1023082484), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David E. Pallares, M.D. have ACO affiliation data?

David E. Pallares, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to David E. Pallares, M.D.?

David E. Pallares, M.D. is linked to PSF PLLC (billing NPI 1881785947) in the available physician profile data.

Does David E. Pallares, M.D. have Open Payments data?

David E. Pallares, M.D. has 122 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.